[剂量和分割方式对非小细胞肺癌根治性放疗的影响] - Suppr

Suppr

超能文献

[Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer].

作者信息

Nieder Carsten

机构信息

Dept. of Oncology and Palliative Medicine, Nordland Hospital Trust, Prinsensgate 164, 1480, 8092, Bodø, Norwegen.

出版信息

Strahlenther Onkol. 2017 Mar;193(3):240-242. doi: 10.1007/s00066-017-1096-y.

DOI:10.1007/s00066-017-1096-y

PMID:28120007

Abstract

摘要

相似文献

[Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer].

Strahlenther Onkol. 2017 Mar;193(3):240-242. doi: 10.1007/s00066-017-1096-y.

Radiation therapy alone in elderly with early stage non-small cell lung cancer.

Lung Cancer. 2006 May;52(2):149-54. doi: 10.1016/j.lungcan.2005.12.010. Epub 2006 Mar 3.

A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer.

J Med Imaging Radiat Oncol. 2013 Feb;57(1):105-12. doi: 10.1111/j.1754-9485.2012.02470.x. Epub 2013 Jan 17.

Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.

Radiother Oncol. 2005 Nov;77(2):176-81. doi: 10.1016/j.radonc.2005.10.001. Epub 2005 Oct 26.

Outcomes treating stage III non-small cell lung carcinoma with curative-intent radiotherapy and concurrent carboplatin-paclitaxel chemotherapy.

Clin Respir J. 2016 Jul;10(4):428-34. doi: 10.1111/crj.12233. Epub 2014 Dec 1.

Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.

Technol Cancer Res Treat. 2014 Jun;13(3):269-75. doi: 10.7785/tcrt.2012.500375. Epub 2013 Sep 20.

Predicting 2-year survival for radiation regimens in advanced non-small cell lung cancer.

Clin Oncol (R Coll Radiol). 2013 Dec;25(12):697-705. doi: 10.1016/j.clon.2013.07.011. Epub 2013 Aug 17.

[A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].

Cancer Radiother. 2001 Apr;5(2):199.

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.

J Clin Oncol. 2001 Jan 1;19(1):127-36. doi: 10.1200/JCO.2001.19.1.127.

Dose-escalated radiotherapy for stage III unresectable non-small cell lung cancer: have we come to a standstill?

Clin Oncol (R Coll Radiol). 2013 Dec;25(12):739-40. doi: 10.1016/j.clon.2013.08.007. Epub 2013 Sep 3.

引用本文的文献

Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases.

Radiat Oncol. 2023 Jun 7;18(1):98. doi: 10.1186/s13014-023-02291-8.

Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?

Radiat Oncol. 2019 Dec 31;15(1):2. doi: 10.1186/s13014-019-1444-4.

本文引用的文献

PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.

Trials. 2016 Nov 15;17(1):543. doi: 10.1186/s13063-016-1679-4.

Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):736-747. doi: 10.1016/j.ijrobp.2016.07.022. Epub 2016 Jul 25.

A critical review of recent developments in radiotherapy for non-small cell lung cancer.

Radiat Oncol. 2016 Sep 6;11(1):115. doi: 10.1186/s13014-016-0693-8.

SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.

Radiother Oncol. 2016 Oct;121(1):1-8. doi: 10.1016/j.radonc.2016.08.015. Epub 2016 Sep 3.

Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.

Ann Oncol. 2016 Oct;27(10):1887-94. doi: 10.1093/annonc/mdw276. Epub 2016 Aug 8.

PLoS One. 2016 Jun 14;11(6):e0157455. doi: 10.1371/journal.pone.0157455. eCollection 2016.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16.

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Strahlenther Onkol. 2012 Oct;188(10):894-900. doi: 10.1007/s00066-012-0161-9. Epub 2012 Aug 31.

HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26.

Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):120-6. doi: 10.1016/j.ijrobp.2005.06.029. Epub 2005 Sep 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验